Galmed Pharmaceuticals and Tissue Dynamics announced positive preclinical results for a combination therapy involving Aramchol Meglumine and a selective PPARα agonist in treating cardiac fibrosis. The study, using human cardiac organoid models, demonstrated a significant reduction in fibrotic burden and highlighted a previously unrecognized metabolic pathway. Galmed's stock surged 15% following the news, and the companies are preparing for IND-enabling activities.

This article identifies top pre-market gainers and losers on Friday, January 5, 2024. It details stock performance, including percentage changes and specific price points for companies like DSS INC, DERMATA THERAPEUTICS INC, GRAPHITE BIO INC, and AGILON HEALTH INC, also noting any recent news or past performance impacting their current trading.

Natixis Advisors LLC reduced its stake in The TJX Companies, Inc. by 1.0% in the fourth quarter, selling 14,205 shares while still holding over 1.4 million shares valued at approximately $217.9 million. This news comes as TJX reported strong quarterly results, beating EPS and revenue expectations, and increased its quarterly dividend. Wall Street analysts generally maintain a "Buy" rating for TJX with a consensus price target of $174.58.

Thompson Siegel & Walmsley LLC significantly increased its stake in United Rentals (NYSE: URI) by 398.7% in the fourth quarter, now holding 7,880 shares valued at $6.38 million. Analysts maintain a "Moderate Buy" rating with an average price target of $1,006.13, despite the company reporting mixed quarterly results by missing earnings and revenue estimates. Shares of United Rentals are trading near their 12-month high, and the company recently paid a quarterly dividend of $1.97 per share.

This article provides access to the latest SEC filings for the First Trust Health Care AlphaDEX Fund (FXH) up to 2026, detailing the different types of filings such as 10-K, 10-Q, and 8-K. It explains the importance of these documents for investors, clarifying their legal obligation, audited nature, and role in evaluating a company's financial health. The page also offers tools to browse and filter these filings and defines key SEC document types.

Flutter Entertainment PLC (FLUT) saw a 7.6% share price increase, but its current price of $104.31 remains significantly below its GF Value™ of $308.34, suggesting undervaluation with 66.2% upside potential. Despite a favorable GF Score™ of 69/100 and strong growth potential, low valuation and momentum ranks, coupled with net insider selling of $1.5 million, advise caution due to potential value trap risks and declining year-to-date performance.

Concorde Asset Management recently invested $3.28 million in the First Trust Senior Loan Fund (FTSL), acquiring 73,167 shares. This strategic move, representing 1.61% of Concorde's assets under management, aims to boost income and reduce interest rate sensitivity within its diversified client portfolios. FTSL is an actively managed ETF focused on high current income from floating-rate senior secured bank loans, offering a 30-day SEC yield of 6.4% and an effective duration of only 0.62 years.

Southwest Airlines has announced a reshuffling of its leadership team, including the appointment of a new chief commercial officer. These changes are part of an ongoing business overhaul at the Dallas-based carrier, with CEO Bob Jordan stating they aim for greater clarity, stronger execution, and deeper connection.

NiSource Inc. (US65473P1057) shares traded roughly flat on the NYSE, with investors anticipating the next quarterly earnings update as the primary catalyst. The regulated utility stock remained in the mid-40 USD range, reflecting broader sector sentiment rather than company-specific news. Attention will now turn to regulatory decisions, capital expenditure plans, and guidance updates for future expectations.

Waterloo Capital L.P. significantly reduced its stake in FS KKR Capital Corp. (NYSE:FSK) by 83.4% in the fourth quarter, selling over 180,000 shares. This comes amidst cautious analyst sentiment, with a consensus "Reduce" rating and numerous downgraded price targets following the company's recent miss on earnings and revenue estimates. Despite these challenges, FS KKR Capital declared a quarterly dividend yielding 15.3%, while also facing multiple class-action lawsuits regarding alleged misleading portfolio valuation disclosures.